Unknown

Dataset Information

0

Combining Watchman left atrial appendage closure and catheter ablation for atrial fibrillation: multicentre registry results of feasibility and safety during implant and 30 days follow-up.


ABSTRACT: Aims:Long-term results from catheter ablation therapy for atrial fibrillation (AF) remain uncertain and clinical practice guidelines recommend continuation of long-term oral anticoagulation in patients with a high stroke risk. Left atrial appendage closure (LAAC) with Watchman has emerged as an alternative to long-term anticoagulation for patients accepting of the procedural risks. We report on the initial results of combining catheter ablation procedures for AF and LAAC in a multicentre registry. Methods and results:Data were pooled from two prospective, real-world Watchman LAAC registries running in parallel in Europe/Middle-East/Russia (EWOLUTION) and Asia/Australia (WASP) between 2013 and 2015. Of the 1140 patients, 139 subjects at 10 centres underwent a concomitant AF ablation and LAAC procedure. The mean CHA2DS2-VASc score was 3.4?±?1.4 and HAS-BLED score 1.5?±?0.9. Successful Watchman implantation was achieved in 100% of patients. The overall 30-day serious adverse event (SAE) rate was 8.7%, with the device and/or procedure-related SAE rate of 1.4%. One pericardial effusion required percutaneous drainage, but there were no strokes, device embolization, or deaths at 30 days. The 30-day bleeding SAE rate was 2.9% with 55% of patients prescribed NOAC and 38% taking warfarin post-procedure. Conclusion:The outcomes from these international, multicentre registries support the feasibility and safety of performing combined procedures of ablation and Watchman LAAC for patients with non-valvular AF and high stroke risk. Further data are needed on long-term outcomes for the hybrid technique on all-cause stroke and mortality.

SUBMITTER: Phillips KP 

PROVIDER: S-EPMC5982721 | biostudies-literature | 2018 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Combining Watchman left atrial appendage closure and catheter ablation for atrial fibrillation: multicentre registry results of feasibility and safety during implant and 30 days follow-up.

Phillips Karen P KP   Pokushalov Evgeny E   Romanov Aleksandr A   Artemenko Sergey S   Folkeringa Richard J RJ   Szili-Torok Tamas T   Senatore Gaetano G   Stein Kenneth M KM   Razali Omar O   Gordon Nicole N   Boersma Lucas V A LVA  

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 20180601 6


<h4>Aims</h4>Long-term results from catheter ablation therapy for atrial fibrillation (AF) remain uncertain and clinical practice guidelines recommend continuation of long-term oral anticoagulation in patients with a high stroke risk. Left atrial appendage closure (LAAC) with Watchman has emerged as an alternative to long-term anticoagulation for patients accepting of the procedural risks. We report on the initial results of combining catheter ablation procedures for AF and LAAC in a multicentre  ...[more]

Similar Datasets

| S-EPMC10003199 | biostudies-literature
| S-EPMC6739757 | biostudies-literature
| S-EPMC6458488 | biostudies-literature
| S-EPMC9904382 | biostudies-literature
| S-EPMC6174377 | biostudies-literature
| S-EPMC10118629 | biostudies-literature
| S-EPMC10307589 | biostudies-literature
| S-EPMC6400300 | biostudies-literature
| S-EPMC9903160 | biostudies-literature
| S-EPMC9622751 | biostudies-literature